AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1105543
Drug: Promazine 50
RxNorm normalized name: promazine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promazine 50 mg three times daily
Trial: 29105476
Drug: Traditional traction,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional traction, massage and intermediate frequency electro therapy
Trial: 19029171
Drug: Routine glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine glucose lowering therapy
Trial: 15365658
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU calcitonin nasal spray with calcium (500 mg) and vitamin D (200 IU)
Trial: 15365658
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg) and vitamin D (200 IU) alone
Trial: 15365658
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU calcitonin nasal spray
Trial: 1544845
Drug: BW12C (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BW12C (20 mg/kg to 50 mg/kg) with mitomycin C
Trial: 1544845
Drug: BW12C (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BW12C (maintenance infusion of 4-6 mg/kg/hr) with mitomycin C
Trial: 12786622
Drug: Intra-arterial injection
RxNorm normalized name: METHOTREXATE 25 mg in 1 mL INTRA-ARTERIAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-arterial injection of radioactive iodine mixed with Lipiodol
Trial: 8931220
Drug: Intravenous PGE1
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous PGE1 (720 micrograms/day for 3 days)
Trial: 1576624
Drug: Loracarbef (200‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loracarbef (200‐mg capsule BID or 15 mg/kg/day suspension)
Trial: 1576624
Drug: Penicillin VK
RxNorm normalized name: PENICILLIN VK 250MG TAB
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin VK (250‐mg capsule QID or 20 mg/kg/day suspension)
Trial: 24837447
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose sildenafil (25 mg)
Trial: 21215143
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose loading alone
Trial: 21215143
Drug: Oral standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral standardized fat loading alone
Trial: 9584554
Drug: Vanceril treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vanceril treatment
Trial: 2229497
Drug: Interferon alfa‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2b (1.5 x 10(6) IU) injected three times weekly for 3 weeks (cumulative dose of 13.5 million IU)
Trial: 2229497
Drug: Placebo injected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injected three times weekly for 3 weeks
Trial: 369645
Drug: Endolymphatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endolymphatic therapy
Trial: 30274756
Drug: Intra-articular hip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular hip injection (IAHI)
Trial: 25727055
Drug: Dialogical Exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialogical Exposure Therapy
Trial: 22368260
Drug: Tablets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets containing actinidine (sucked three times a day for six days)
Trial: 22368260
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets without actinidine
Trial: 15739120
Drug: Pioglitazone (PIO)
DrugBank: Pioglitazone (DB01132)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pioglitazone (PIO) 30‐45 mg/day
Trial: 15739120
Drug: Pioglitazone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone + Metformin (PIO+MET)
Trial: 15739120
Drug: Gliclazide (GLIC)
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide (GLIC) 80‐320 mg/day
Trial: 15739120
Drug: Gliclazide +
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide + Metformin (GLIC+MET)
Trial: 9701155
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg Zn
Trial: 9701155
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg Zn
Trial: 7832079
Drug: Ofloxacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (300 mg once daily, SID group)
Trial: 7832079
Drug: Ofloxacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (300 mg in three divided doses, TID group)
Trial: 3049876
Drug: Pentoxifylline (Trental)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (Trental) 1200 mg daily (400 mg t.i.d.)
Trial: 29362960
Drug: Combination Exercise
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Exercise (CE)
Trial: 27442397
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion (1000 ml)
Trial: 18574578
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo injection (Group II)
Trial: 16861942
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (tac/MMF/steroids)
Trial: 11076430
Drug: Timolol gel
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol gel 0.5% once daily
Trial: 11076430
Drug: Timolol aqueous
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol aqueous solution 0.5% twice daily
Trial: 9170340
Drug: N-monomethyl-L-arginine (L-NMMA),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of NO-synthase
Trial: 9170340
Drug: N-monomethyl-L-arginine (L-NMMA)
RxNorm normalized name: .alpha.N-(methoxycarbonyl)-L-arginine
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-monomethyl-L-arginine (L-NMMA)
Trial: 8067787
Drug: Rice based
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice based oral rehydration therapy (ORT)
Trial: 3287975
Drug: Cefotetan (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotetan (single 2 g dose)
Trial: 3287975
Drug: Cefoxitin (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (multiple 2 g doses)
Trial: 22474419
Drug: Add-on basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Add-on basal insulin therapy on top of oral agents
Trial: 16086921
Drug: Clopidogrel (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (600 mg loading dose before IRA stenting followed by 75 mg daily)
Trial: 16086921
Drug: Ticlopidine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (500 mg before IRA stenting followed by 250 mg twice daily)
Trial: 17471790
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (14 mg)
Trial: 12126990
Drug: Nicotine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (7 mg)
Trial: 10102963
Drug: Tripotassium dicitrato
RxNorm normalized name: Tripotassium dicitratobismuthate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripotassium dicitrato bismuthate 240 mg b.d. plus furazolidone 100 mg b.d. plus clarithromycin 250 mg b.d. (Group A)
Trial: 10102963
Drug: Clarithromycin 250
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 250 mg b.d. plus amoxycillin 1000 mg b.d. (Group B)
Trial: 10102963
Drug: Furazolidone 100
RxNorm normalized name: furazolidone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furazolidone 100 mg b.d. plus josamycin 1000 mg b.d. (Group C)
Trial: 2572793
Drug: NG monomethyl‐L‐arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NG monomethyl‐L‐arginine (L‐NMMA) infusion into the brachial arteries
Trial: 8872666
Drug: Acetylcholine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcholine infusion
Trial: 2572793
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate infusion
Trial: 1089474
Drug: Four different
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four different drug combinations
Trial: 25421981
Drug: Intensified pharmacological
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified pharmacological treatment
Trial: 22093417
Drug: Aripiprazole (5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (5-25 mg/d)
Trial: 22093417
Drug: Tiapride (100-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapride (100-500 mg/d)
Trial: 17005086
Drug: Yiweining (YWN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yiweining (YWN) 200 ml, twice a day for 6 months
Trial: 17005086
Drug: Gestrinone (GT)
RxNorm normalized name: gestrinone
DrugBank: Gestrinone (DB11619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone (GT) 2.5 mg, twice every week for 6 months
Trial: 12775135
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 200 microg, once daily (FP200QD)
Trial: 12775135
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg, once daily (MON10QD)
Trial: 9185464
Drug: Diltiazem (1‐3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (1‐3 mcg.kg‐1.min‐1)
Trial: 3803417
Drug: Acipimox, 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox, 250 mg three times daily
Trial: 31541431
Drug: Venetoclax (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venetoclax (single doses of 10–500 mg or two cycles of 30–600 mg or placebo once daily for 7 days followed by a 21-day washout)
Trial: 31541431
Drug: Continuous dosing
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous dosing with lower doses of venetoclax (e.g., 150 mg daily)
Trial: 31541431
Drug: Cyclic dosing
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic dosing with higher doses (e.g., 400 mg 1 week on/3 weeks off)
Trial: 29752954
Drug: Complete fasting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete fasting with placebo treatment
Trial: 29752954
Drug: Leptin treatment
RxNorm normalized name: leptin
DrugBank: Leptin (DB05098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin treatment vs placebo
Trial: 29752954
Drug: Leptin treatment
RxNorm normalized name: leptin
DrugBank: Leptin (DB05098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin treatment in women with HA
Trial: 27254034
Drug: YF vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YF vaccine with CYD‐TDV
Trial: 27254034
Drug: YF vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YF vaccine with placebo
Trial: 27254034
Drug: CYD‐TDV after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD‐TDV after 2 injections
Trial: 27254034
Drug: CYD‐TDV after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD‐TDV after 2 injections (placebo group)
Trial: 25083606
Drug: Confocal laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Confocal laser endomicroscopy (CLE) with food antigens administered directly to the duodenal mucosa.
Trial: 17891480
Drug: 250‐mg caffeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250‐mg caffeine
Trial: 17891480
Drug: 200‐mg theanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200‐mg theanine
Trial: 16025736
Drug: Benidipine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benidipine 4 mg
Trial: 8708496
Drug: Oral electrolyte
RxNorm normalized name: Hydralyte Oral Electrolyte Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral electrolyte solution made with rice syrup solids
Trial: 8708496
Drug: Comparable glucose-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparable glucose-based solution
Trial: 1874580
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily - morning and 19h30
Trial: 1874580
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily - morning and 22h30
Trial: 1874580
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg once daily at 19h30
Trial: 1874580
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg once daily at 22h30
Trial: 31306495
Drug: Dupilumab (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dupilumab (600 mg loading dose, then 300 mg once weekly for 15 weeks)
Trial: 28774488
Drug: Lactated Ringer
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer solution (crystalloid)
Trial: 20676755
Drug: Recent aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recent aspirin use
Trial: 17462588
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy methods focusing on childhood memories
Trial: 17462588
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy methods focusing on the present
Trial: 11338045
Drug: No neoadjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No neoadjuvant chemotherapy (Control)
Trial: 10423597
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 mg/d)
Trial: 10423597
Drug: Gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (600 mg twice a day)
Trial: 7515382
Drug: Xylometazoline 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylometazoline 0.1% vasoconstrictor nasal spray
Trial: 20339969
Drug: Nebivolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (5 mg daily for 4 weeks)
Trial: 17629923
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate (SFC) 50/100 mug twice daily
Trial: 17629923
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 mug twice daily
Trial: 15668601
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein containing 52 mg genistein, 41 mg daidzein, and 6 mg glycitein daily for 1 year
Trial: 15668601
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein (placebo) daily for 1 year
Trial: 12029552
Drug: Iodine-131 iodide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodine-131 iodide (120 MBq) as diagnostic agent, followed by ablation activity of 131I iodide (4,000 MBq) administered 3-38 days later.
Trial: 12029552
Drug: Iodine-123 iodide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodine-123 iodide (200 MBq) as diagnostic agent, followed by ablation activity administered 5-47 days later.
Trial: 7492128
Drug: Colchicine, 0.5
RxNorm normalized name: Colchicine, 0.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine, 0.5 mg twice daily
Trial: 394315
Drug: Oral streptokinase/streptodornase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral streptokinase/streptodornase
Trial: 26014294
Drug: Bevacizumab (B)
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab (B) 15 mg/kg intravenously plus Carboplatin (CP) and Paclitaxel (CP)
Trial: 23907665
Drug: GSK1322322 (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1322322 (oral or intravenous administration)
Trial: 23907665
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral doses of GSK1322322 (1,000 and 1,500 mg)
Trial: 23907665
Drug: Repeat IV
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat IV doses of GSK1322322 (500 to 1,500 mg twice daily)
Trial: 23907665
Drug: Supratherapeutic single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supratherapeutic single IV doses of GSK1322322 (2,000 and 3,000 mg)
Trial: 20717049
Drug: Bevacizumab (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (1.25 mg in 0.05 mL) injected around the valve body after surgery
Trial: 20717049
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (0.4 mg/mL for 3 min) applied before valve implantation
Trial: 19086709
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 to 100 mg)
Trial: 7593877
Drug: Maternal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal treatment investment
Trial: 2199847
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (Botox) injections
Trial: 2199847
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (Botox) injections (higher dose during open phase)
Trial: 28898378
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEE, 0.625 mg/d) plus medroxyprogesterone acetate (MPA, 2.5 mg/d) (n=8506)
Trial: 28898378
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEE, 0.625 mg/d) alone (n=5310)
Trial: 28898378
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (CEE+MPA or CEE)
Trial: 24212847
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (hypotensive eyedrops)
Trial: 22013796
Drug: Wangbi Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wangbi Tablet (WT)
Trial: 22013796
Drug: WT +
RxNorm normalized name: semaglutide
DrugBank: Semaglutide (DB13928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: WT + Votalin Tablet
Trial: 22013796
Drug: Votalin Tablet
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Votalin Tablet
Trial: 7669459
Drug: Oral naproxen
RxNorm normalized name: naproxen Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naproxen 1 g
Trial: 2040354
Drug: Porcine surfactant
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine surfactant (Curosurf, 200 mg/kg body weight)
Trial: 7044788
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg orgotein (intra-articular injections, 4 weekly)
Trial: 7044788
Drug: Saline (intra-articular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (intra-articular injections, 4 weekly)
Trial: 31559433
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (3000 IU daily for 26 weeks)
Trial: 21902692
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg clopidogrel
Trial: 7979499
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (enteral nutrition or corticosteroids)
Trial: 20460239
Drug: Fortified soymilk
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fortified soymilk (20 mL with 185 kBq of 45Ca in 44 mg of calcium carrier)
Trial: 17570262
Drug: Medium-chain triglyceride
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-chain triglyceride (MCT), 18 g/d for 90 days
Trial: 16034259
Drug: 50 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ml syringe training aid
Trial: 6996107
Drug: Propoxyphene hydrochloride
RxNorm normalized name: Propoxyphene Hydrochloride
DrugBank: Dextropropoxyphene (DB00647)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propoxyphene hydrochloride (64 mg)
Trial: 30106311
Drug: Emulsified cod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emulsified cod liver oil formulation